Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG , a world leader in offering medicines to protect health, treat disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

* Known as Gl
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:5/29/2015)... May 29, 2015  Today, UL LLC, a ... global provider of electronic quality management systems (EQMS) ... which will leverage the strengths of both organizations ... system implementation and comprehensive advice and guidance for ... EQMS capabilities to UL,s strength in regulatory services ...
(Date:5/29/2015)... 2015  Anpac Bio-Medical Science Co., Ltd., Chief Executive ... the Anpac research team are introducing what the 2015 ... published as, "game changing" and "breakthrough" early cancer detection ... Oncology (ASCO) Annual Meeting in Chicago, Illinois ... An accomplished inventor with over 200 patent ...
(Date:5/29/2015)... , May 29, 2015  Fair Rate Funding, a ... state-court jury in Delaware found ... designed to treat pelvic organ prolapse (POP) and Stress ... that company executives hid the design flaws from the ... http://photos.prnewswire.com/prnh/20150529/219354LOGO Transvaginal mesh, also ...
Breaking Medicine Technology:UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3
... (NYSE: SHP ) ("ShangPharma" or the ... and development outsourcing company, today announced that it ... for the year ended December 31, 2011 with ... "SEC"). The annual report can be accessed on ...
... JAZZ ) today announced that it will host ... 2012 at 4:30 p.m. EDT/9:30 p.m. IST. During the call, ... review first quarter 2012 results. A live webcast ... of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com ...
Cached Medicine Technology:ShangPharma Corporation Files 2011 Annual Report on Form 20-F 2
(Date:5/29/2015)... Newport, Rhode Island (PRWEB) May 29, 2015 ... June 7, 2015. The event, now closed to new ... Landmark Fort Adams. This exciting competitive running event ... non-profit organizations to create a public benefit – in ... Newport’s scenic coastal views around the famed Ocean Drive ...
(Date:5/29/2015)... 2015 The Recovery Village at ... and co-occurring mental health treatment facility, will host ... the general public on June 1st, and will ... Village at Palmer Lake will offer affordable detox, ... traditional and evidence-based therapies, in a luxurious setting ...
(Date:5/29/2015)... 29, 2015 According to a recent HealthDay ... full-time workers has a substance abuse problem - the data, ... 111,500 adults with full-time jobs, revealed that 9.5% of those ... year. (1) The National Council on Alcoholism and Drug Dependence ... and an estimated 70% of the 14.8 million illicit drug ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, ... God does no wrong. , It’s fitting, then, that her ... titled “God Does No Wrong.” It focuses on what happens ... , “My story has a positive message about channeling ... productive, something healing,” Howse said. , “God Does No Wrong” ...
(Date:5/29/2015)... May 29, 2015 The Healthcare ... graduates of its Advanced Training Program (ATP) in ... fill roles in their health care organization ranging ... and methodology of continuous quality improvement in the ... to Dr. Brent James’ internationally recognized Advanced Training ...
Breaking Medicine News(10 mins):Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Turning grief from a child’s passing into virtue 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2
... Department of Agriculture's (USDA) Food Safety and Inspection Service ... public //that a consignment of pork products that were ... wholesale establishments in the state of Ohio , ... Listeria monocytogenes This was established through microbiological testing. ...
... the import of poultry, eggs and related products from India ... ,Bhutan had imposed an indefinite ban on the import of ... the H5N1 virus in poultry in India's Maharashtra state. On ... which had led to the culling of millions of infected ...
... Researchers at University of Utah’s Huntsman Cancer Institute have discovered ... a molecule that is implicated in 85 percent of colon ... is, genetically disabling – a molecule called C-Terminal Binding Protein ... of a mutation in the adenomatous polyposis coli (APC) gene. ...
... be fought with a combined treatment of hormonal therapy and ... the progress of breast cancer by over half, according to ... been made for the treatment to be made available for ... showed that the addition of Herceptin to hormonal therapy kept ...
... The need for more awake surgery was made at a ... Irish Cancer Society. // , ,According to the ... time-consuming and expensive, it has higher rate of success and ... Cancer Registry’s recent data reveal that there were 316 new ...
... to carry out a stomach-stapling surgery by introducing a tube ... ,Around 1 million bariatric surgeries have been carried ... loss and it involves stapling of the stomach, making it ... the surgery without incisions will make it a lower-risk, lower-cost ...
Cached Medicine News:Health News:Bhutan Lifts Ban on Poultry from India 2Health News:A New Way to Treat Colon Cancer? 2Health News:Awake Surgery to treat Brain tumours 2Health News:NOTE surgery – to combat obesit 2
... with superior aspherical optics. The separation of ... the aspherical optical system avoids corneal and ... you to view the whole of the ... a small pupil. Conventional ophthalmoscopes often let ...
... The Panoptic ophthalmoscope incorporates an innovative ... axial Pointsource optics. This enabling technology ... pupils and provides a dramatically wider, ... that's 5X larger than ever before ...
... RT-300's accessory knob is positioned next to ... are within a hand's breadth of each ... power from +16.75 to -19.00D. "Sure-grip" knurls ... to grasp. Combined with the convenient placement ...
Double Maddox...
Medicine Products: